UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003274 |
|---|---|
| Receipt number | R000003960 |
| Scientific Title | A phase II trial of gefitinib and concurrent radiation therapy for locally advanced non-small cell lung cancer patients harboring sensitive EGFR mutations. |
| Date of disclosure of the study information | 2010/03/01 |
| Last modified on | 2011/09/02 09:26:00 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/03/01 12:24:19 | ||
| 2 | Update | 2010/03/01 16:02:25 | Key inclusion criteria Key inclusion criteria |
|
| 3 | Update | 2010/05/26 14:35:19 | Recruitment status |
|
| 4 | Update | 2010/09/01 15:55:40 | Name of person sending information Organization Division name Address |
|
| 5 | Update | 2011/05/13 21:10:31 | Key inclusion criteria Key inclusion criteria |
|
| 6 | Update | 2011/05/13 21:11:39 | Recruitment status |
|
| 7 | Update | 2011/09/02 09:26:00 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
